The Diabetic Retinopathy "Pandemic" and Evolving Global Strategies: The 2023 Friedenwald Lecture.
Journal Information
Full Title: Invest Ophthalmol Vis Sci
Abbreviation: Invest Ophthalmol Vis Sci
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Ophthalmology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Disclosure: T.Y. Wong, Bayer (C), Boehringer-Ingelheim (C), Eden Ophthalmic (C), Genentech (C), Iveric Bio (C), Merck (C), Novartis (C), Plano (C), Oxurion (C), Roche (C), Shanghai Henlius (C), Zhaoke Pharmaceutical (C), Coinventor, with patents pending, for a deep learning system for diabetic retinopathy, glaucoma, and agerelated macular degeneration (SG NonProvisional Application number 10201706186V), and a computer implemented method for training an image classifier using weakly annotated training data (SG Provisional Patent Application number 10201901083Y); Cofounder and shareholder of EyRIS Pte Ltd., Singapore and VISRE, Singapore; T.-E. Tan, None"
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025